First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin

Vaccine

Volumn 27, Issue 43, 2009, Pages 6034-6041

  Bouchez, V ^a   Brun, D ^a   Cantinelli, T ^b   Dore, G ^a   Njamkepo, E ^a   Guiso, N ^a  

^a CNRS   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

Bordetella pertussis; Pertactin; Pertussis toxin

Indexed keywords

ADENYLATE CYCLASE; PERTACTIN; PERTUSSIS TOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM EXAMINATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BORDETELLA PERTUSSIS; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE DELETION; GENE LOCATION; GENE SEQUENCE; GENOME ANALYSIS; LYMPHOCYTOSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULSED FIELD GEL ELECTROPHORESIS; PYROSEQUENCING; SEQUENCE ANALYSIS; SEROTYPING; STRAIN DIFFERENCE; WESTERN BLOTTING;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL TYPING TECHNIQUES; BORDETELLA PERTUSSIS; CELL LINE; COMPARATIVE GENOMIC HYBRIDIZATION; DNA, BACTERIAL; FEMALE; FRANCE; GENE DELETION; GENES, BACTERIAL; GENOTYPE; HUMANS; INFANT; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERTUSSIS TOXIN; PERTUSSIS VACCINE; SEQUENCE ANALYSIS, DNA; VIRULENCE FACTORS, BORDETELLA; WHOOPING COUGH;

EID: 70349267512     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.07.074     Document Type: Article

References (34)

1. Baron S., Njamkepo E., Grimprel E., Begue P., Desenclos J.C., Drucker J., et al. Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr Inf Dis J 17 5 (1998) 412-418
2. Wendelboe A.M., Njamkepo E., Bourillon A., Floret D.D., Gaudelus J., Gerber M., et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 26 4 (2007) 293-299
3. Wirsing von Konig C.H., Halperin S., Riffelmann M., and Guiso N. Pertussis of adults and infants. Lancet Infect Dis 2 12 (2002) 744-750
4. Anonymous. Calendrier vaccinal 2008-Avis du Haut conseil de la santé publique. Bull Epidemiol Heb 16-17 (2008) 1-20
5. Bonmarin I., Levy-Bruhl D., Baron S., Guiso N., Njamkepo E., and Caro V. Pertussis surveillance in French hospitals: results from a 10 year period. Euro Surveill 12 1 (2007). http://www.eurosurveillance.org/em/v12n01/1201-226.asp
6. Briand V., Bonmarin I., and Levy-Bruhl D. Study of the risk factors for severe childhood pertussis based on hospital surveillance data. Vaccine 25 41 (2007 Oct 10) 7224-7232
7. Caro V., Hot D., Guigon G., Hubans C., Arrive M., Soubigou G., et al. Temporal analysis of French Bordetella pertussis isolates by comparative whole-genome hybridization Bordetella pertussis, Finland and France. Microb Infect 8 8 (2006) 2228-2235
8. Weber C., Boursaux-Eude C., Coralie G., Caro V., and Guiso N. Polymorphism of Bordetella pertussis isolates circulating the last ten years in France, where a single effective whole-cell vaccine has been used for more than thirty years. J Clin Microbiol 39 12 (2001) 4396-4403
9. Bouchez V., Caro V., Levillain E., Guigon G., and Guiso N. Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination. PLoS ONE 3 6 (2008) e2437
10. Mooi F.R., He Q., and Guiso N. Phylogeny, evolution and epidemiology of Bordetellae. In: Camille Locht INSERM U629, and Institut Pasteur de Lille F (Eds). Bordetella: molecular microbiology (2007), Horizon Bioscience, Norfolk, United Kingdom 17-45
11. Njamkepo E., Cantinelli T., Guigon G., and Guiso N. Genomic analysis and comparison of Bordetella pertussis isolates circulating in low and high vaccine coverage areas. Microb Infect 10 November-December (14-15) (2008) 1582-1586
12. Caro V., Njamkepo E., Van Amersfoorth S.C., Mooi F.R., Advani A., Hallander H.O., et al. Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microb Infect 7 7-8 (2005) 976-982
13. Mooi F.R., Hallander H., Wirsing von Köning C.H., Hoet B., and Guiso N. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur Clin Infect Dis J 19 (2000) 174-181
14. Fry N.K., Neal S., Harrison T.G., Miller E., Matthews R., and George R.C. Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect Immun 69 9 (2001) 5520-5528
15. Guiso N., von Konig C.H.W., Becker C., and Hallander H. Fimbrial typing of Bordetella pertussis isolates: agglutination with polyclonal and monoclonal antisera. J Clin Microbiol 39 4 (2001) 1684-1685
16. Ladant D., Brezin C., Alonso J.-M., Crenon I., and Guiso N. Bordetella pertussis adenylate cyclase. Purification, characterization, and radioimmunoassay. J Biol Chem 261 34 (1986) 16264-16269
17. Bassinet L., Gueirard P., Maitre B., Housset B., Gounon P., and Guiso N. Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis. Infect Immun 68 4 (2000) 1934-1941
18. Khelef N., Zychlinsky A., and Guiso N. Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin. Infect Immun 61 10 (1993) 4064-4071
19. Boursaux-Eude C., Thiberge G., Carletti G., and Guiso N. Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine. Vaccine 17 (1999) 2651-2660
20. Guiso N., Capiau C., Carletti G., Poolman J., and Hausser P. Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines. Vaccine 17 (1999) 2366-2376
21. Parkhill J., Sebaihia M., Preston A., Murphy L.D., Thomson N., Harris D.E., et al. Comparative analysis of the genome sequences of Bordetella pertussis. Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 35 1 (2003) 32-40
22. Caro V., Bouchez V., and Guiso N. Is the sequenced Bordetella pertussis strain Tohama I representative of the species?. J Clin Microbiol 46 6 (2008) 2125-2128
23. King A.J., van Gorkom T., Pennings J.L., van der Heide H.G., He Q., Diavatopoulos D., et al. Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains. BMC Genom 9 1 (2008) 311
24. Packard E.R., Parton R., Coote J.G., and Fry N.K. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J Med Microbiol 53 Pt 5 (2004) 355-365
25. Van Loo I.H., Heuvelman K.J., King A.J., and Mooi F.R. Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J Clin Microbiol 40 6 (2002) 1994-2001
26. Maharjan R.P., Gu C., Reeves P.R., Sintchenko V., Gilbert G.L., and Lan R. Genome-wide analysis of single nucleotide polymorphisms in Bordetella pertussis using comparative genomic sequencing. Res Microbiol 26 (2008) 26
27. Denoel P., Godfroid F., Guiso N., Hallander H., and Poolman J. Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model. Vaccine 26 (2005) 26
28. Njamkepo E., Guillemot L., and Guiso N. Is Bordetella pertussis and parapertussis pathogenicity changing with time?. Eighth international symposium saga of the genus Bordetella (2006), Institut Pasteur, Paris E1-10
29. Brinig M.M., Cummings C.A., Sanden G.N., Stefanelli P., Lawrence A., and Relman D.A. Significant gene order and expression differences in Bordetella pertussis despite limited gene content variation. J Bacteriol 188 7 (2006) 2375-2382
30. Cummings C.A., Brinig M.M., Lepp P.W., van de Pas S., and Relman D.A. Bordetella species are distinguished by patterns of substantial gene loss and host adaptation. J Bacteriol 186 5 (2004) 1484-1492
31. Heikkinen E., Kallonen T., Saarinen L., Sara R., King A.J., Mooi F.R., et al. Comparative genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains. PLoS ONE 2 9 (2007) e904
32. Moran N.A., and Plague G.R. Genomic changes following host restriction in bacteria. Curr Opin Genet Dev 14 December (6) (2004) 627-633
33. Plague G.R., Dunbar H.E., Tran P.L., and Moran N.A. Extensive proliferation of transposable elements in heritable bacterial symbionts. J Bacteriol 190 2 (2008) 777-779
34. Boursaux-Eude C., and Guiso N. Polymorphism of repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica. Infect Immun 68 8 (2000) 4815-4817